Protocol for lentiviral vector-based gene transfection in human ILC2s
Misato Irie1, Hiroki Kabata1, Koichi Fukunaga1
1Keio University School of Medicine, Department of Medicine, Division of Pulmonary Medicine, Tokyo, Japan.
STAR Protocols
|January 31, 2024
Summary
Researchers developed a new lentiviral vector method to modify gene expression in human group 2 innate lymphoid cells (ILC2s), crucial for immunology research.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Modifying gene expression in lymphocytes is critical for immunological studies.
- Established gene transfection protocols for group 2 innate lymphoid cells (ILC2s) are lacking.
Purpose of the Study:
- To present a reliable protocol for gene delivery into human ILC2s using lentiviral vectors.
- To enable gene overexpression or suppression for studying ILC2 biology.
Main Methods:
- Detailed protocol for lentiviral solution preparation.
- Step-by-step guide for transfection of human ILC2s.
- Methods for selection of successfully transfected cells.
Main Results:
- Successful introduction of genes into human ILC2s.
- Demonstrated ability to overexpress or suppress specific genes.
- Facilitated evaluation of functional changes in ILC2 biology.
Conclusions:
- The presented lentiviral vector protocol provides an effective means to genetically modify human ILC2s.
- This method supports advanced research into ILC2 function and immunology.
Keywords:
Cell BiologyCell cultureCell isolationCell-based AssaysGene ExpressionImmunologyMolecular BiologyMore Related Videos
06:33Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
Published on: February 16, 2024
1.2K
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
15.3K
